Bill Miller Viatris Inc Transaction History

Miller Value Partners, LLC

$177 Billion
Q3 2024

A detailed history of Bill Miller (Miller Value Partners, LLC) transactions in Viatris Inc stock. As of the latest transaction made, Miller Value Partners, LLC holds 619,000 shares of VTRS stock, worth $8.05 Million. This represents 4.06% of its overall portfolio holdings.

Number of Shares

619,000

Previous 619,000 -0.0%

Holding current value

$8.05 Million

Previous $6.58 Billion 9.22%

% of portfolio

4.06%

Previous 4.2%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$11.27 - $13.53 $1.04 Million - $1.25 Million	-92,500 Reduced 13.0%	619,000 $7.39 Billion
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $1.09 Million - $1.29 Million	-114,000 Reduced 13.81%	711,500 $7.02 Billion
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $523,160 - $596,820	-58,000 Reduced 6.56%	825,500 $8.24 Billion
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $552,000 - $735,600	-60,000 Reduced 6.36%	883,500 $8.5 Million
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $288,320 - $378,420	-34,000 Reduced 3.48%	943,500 $8.04 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $515,025 - $808,500	52,500 Added 5.68%	977,500 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $2.42 Million - $2.94 Million	200,000 Added 27.59%	925,000 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $1.33 Million - $1.51 Million	100,000 Added 16.0%	725,000 $9.82 Million
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $1.62 Million - $2.02 Million	125,000 Added 25.0%	625,000 $8.93 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $6.8 Million - $9.27 Million	500,000 New	500,000 $6.99 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track Bill Miller's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.

Account